DYNE THERAPEUTICS INC (DYN) Stock Income Statement
NASDAQ:DYN - Nasdaq - US26818M1080 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 343.89M | 242.16M | 170.96M | 150.03M | 58.65M | |||
| Research and Development | 281.41M | 210.76M | 142.76M | 121.31M | 45.20M | |||
| Selling, General, and Administrative Expenses | 62.48M | 31.40M | 28.20M | 28.72M | 13.45M | |||
| Operating Income | -343.89M | -242.16M | -170.96M | -150.03M | -58.65M | |||
| Interest Income/Expense | 26.92M | 7.64M | 2.92M | 740.00K | -340.00K | |||
| Other Income/Expense | -454.00K | -1.42M | -50.00K | -10.00K | -450.00K | |||
| Income Before Taxes | -317.42M | -235.94M | -168.10M | -149.29M | -59.44M | |||
| Net Income | -317.42M | -235.94M | -168.10M | -149.29M | -59.44M | |||
| EBITDA | -342.21M | -240.49M | -169.28M | -148.94M | -57.95M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.37 | -3.95 | -3.23 | -2.93 | -1.32 | |||
| Non GAAP EPS | -3.35 | -3.94 | -3.24 | -2.91 | N/A | |||
| Statistics | ||||||||
All data in USD